Postmenopausal Osteoporosis

Please join us for an educational presentation on the importance of identifying patients with postmenopausal osteoporosis at high risk for fracture, determining their degree of risk, and criteria for the use of anabolic therapy as an initial therapy option. With a dual effect that both builds bone and to a lesser extent slows bone loss. EVENITY has been shown to build bone rapidly in 12 months and reduce the risk of new vertebral fractures.

Intended audience: Providers who may prescribe osteoporosis medications, nursing, pharmacists